6
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Protracted Infusion of 5-FU with Weekly Low-Dose Cisplatin as Second-Line Therapy in Patients with Metastatic Colorectal Cancer Who Have Failed 5-FU Monotherapy

, , , , , & show all
Pages 27-33 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (10)

Gaetano Marverti, Gaia Gozzi, Eleonora Maretti, Angela Lauriola, Leda Severi, Francesca Sacchetti, Lorena Losi, Salvatore Pacifico, Stefania Ferrari, Glauco Ponterini, Eliana Leo, Maria Paola Costi & Domenico D’Arca. (2020) A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells. International Journal of Molecular Sciences 21:12, pages 4452.
Crossref
Ren? Adam, Bin Yi, Pasquale F. Innominato, Eduardo Barroso, Christophe Laurent, Felice Giuliante, Lorenzo Capussotti, R?al Lapointe, Jean-Marc Regimbeau, Santiago Lopez-Ben, Helena Isoniemi, Catherine Hubert, Jen-Kou Lin, Thomas Gruenberger, Dominique Elias, Oleg G. Skipenko & Alfredo Guglielmi. (2017) Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients. European Journal of Cancer 78, pages 7-15.
Crossref
Fumitake Hata, Kazuaki Sasaki, Koichi Hirata, Susumu Yamamitsu & Tetsuhiko Shirasaka. (2008) Efficacy of a continuous venous infusion of fluorouracil and daily divided dose cisplatin as adjuvant therapy in resectable colorectal cancer: A prospective randomized trial. Surgery Today 38:7, pages 623-632.
Crossref
René Adam, Thomas Aloia, Francis Lévi, Dennis A. Wicherts, Robbert J. de Haas, Bernard Paule, Marie-Pierre Bralet, Mohamed Bouchahda, David Machover, Michel Ducreux, Vincent Castagne, Daniel Azoulay & Denis Castaing. (2007) Hepatic Resection After Rescue Cetuximab Treatment for Colorectal Liver Metastases Previously Refractory to Conventional Systemic Therapy. Journal of Clinical Oncology 25:29, pages 4593-4602.
Crossref
Bert H. O’Neil, Hanna Kelly, Michael A. Morse & Richard M. Goldberg. 2007. Colorectal Cancer. Colorectal Cancer 131 154 .
G Aravantinos. (1999) Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy. Critical Reviews in Oncology/Hematology 32:3, pages 209-219.
Crossref
H Bleiberg. (1999) CPT-11 in gastrointestinal cancer. European Journal of Cancer 35:3, pages 371-379.
Crossref
E Van Cutsem, D Cunningham, W.W Ten Bokkel Huinink, C.J.A Punt, C.G Alexopoulos, L Dirix, M Symann, G.H Blijham, P Cholet, G Fillet, C Van Groeningen, J.M Vannetzel, F Levi, G Panagos, C Unger, J Wils, C Cote, C Blanc, P Hérait & H Bleiberg. (1999) Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). European Journal of Cancer 35:1, pages 54-59.
Crossref
G. Codacci-Pisanelli, C.L. van der Wilt, H.M. Pinedo, F. Franchi, P. Noordhuis, B.J.M. Braakhuis, J.A.M. van Laar & G.J. Peters. (1995) Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice. European Journal of Cancer 31:9, pages 1517-1525.
Crossref
Godefridus J. Peters, Giovanni Codacci-Pisanelli, Clasina L. van der Wilt, Jan A. M. van Laar, Kees Smid, Paul Noordhuis & Herbert M. Pinedo. 1993. Novel Approaches to Selective Treatments of Human Solid Tumors. Novel Approaches to Selective Treatments of Human Solid Tumors 9 21 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.